Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients.

Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients.
复制标题

犬乳腺肿瘤患者血清和组织中CA15-3、CEA、SF联合检测

DOI:
10.1038/s41598-021-85029-4
复制
发表时间:
2021-03-23
期刊:
影响因子:
4.6
通讯作者:
Liu Y
Liu Y
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Fan Y;Ren X;Liu X;Shi D;Xu E;Wang S;Liu Y

文献摘要

参考文献

被引文献

相似文献

本研究旨在探讨CA 15 -3、CEA和SF在犬乳腺肿瘤中的表达水平及其临床诊断价值。本研究采用ELISA和qRT-PCR方法检测了178例CMGT患者和健康犬的组织/血清CA 15 -3、CEA和SF水平。恶性肿瘤组CA 15 -3、CEA、SF水平明显高于良性肿瘤组和健康对照组。在恶性肿瘤组中,CA 15 -3的敏感性为51.8%,特异性为93.9%,准确性为76.8%。CEA诊断胃癌的敏感性、特异性和准确性分别为44.6%、84.1%和68.1%。SF的敏感性为62.5%,特异性为85.4%,准确性为76.1%。SF的敏感性最高,CA 15 -3的特异性最高。三种生物标志物联合检测在恶性肿瘤组中的敏感性、特异性和准确性分别为80.4%、78.0%和80.0%,因此联合检测可提高敏感性和准确性,但降低特异性。结论:血清/组织标志物CA 15 -3、CEA、SF联合检测可提高CMGT的检测灵敏度,为临床应用提供参考价值。
The purpose of this study is to evaluate the levels and clinical diagnosis value of CA15-3, CEA, and SF in canine mammary gland tumors (CMGTs). In this study, the levels of tissues/serum CA15-3, CEA, and SF in 178 CMGT patients or healthy dogs were determined by ELISA and qRT-PCR assay. CA15-3, CEA, and SF levels of the malignant tumor group were significantly higher than that of the benign tumor group and the healthy control group. In the malignant tumor group, CA15-3 held a sensitivity of 51.8%, a specificity of 93.9%, and an accuracy of 76.8%. The sensitivity, specificity, and accuracy of CEA were 44.6%, 84.1%, and 68.1% respectively. SF held a sensitivity of 62.5%, a specificity of 85.4%, and an accuracy of 76.1%. SF showed the highest sensitivity and CA15-3 showed the highest specificity. The sensitivity, specificity, and accuracy of the combined detection of the three biomarkers in malignant tumor groups were 80.4%, 78.0%, and 80.0%, respectively, therefore combined detection increased sensitivity and accuracy but decreased specificity. In conclusion, the combined detection of serum/tissue markers CA15-3, CEA, and SF may improve the detection sensitivity of CMGTs, providing reference value for clinical application.
DOI: 10.1002/jcla.22875
发表时间: 2019-06-01
影响因子: 2.7
作者:
Lian, Mingjian;Zhang, Cuixia;Hong, Guolin
通讯作者: Hong, Guolin
DOI: 10.1177/0300985810393258
发表时间: 2011-01-01
影响因子: 2.4
作者:
Goldschmidt, M.;Pena, L.;Zappulli, V.
通讯作者: Zappulli, V.
DOI: 10.1684/abc.2017.1257
发表时间: 2017-07-01
影响因子: 0.5
作者:
Gonssaud, Barbara;Goussot, Vincent;Riedinger, Jean-Marc
通讯作者: Riedinger, Jean-Marc
DOI: 10.1016/j.cca.2015.06.022
发表时间: 2015-08-25
影响因子: 5
作者:
Stieber, Petra;Nagel, Dorothea;Di Gioia, Dorit
通讯作者: Di Gioia, Dorit
DOI: 10.1186/s13028-018-0417-1
发表时间: 2018-10-29
影响因子: 2.1
作者:
Kaszak I;Ruszczak A;Kanafa S;Kacprzak K;Król M;Jurka P
通讯作者: Jurka P